Skip to main content
. 2018 Dec 5;148(12):1886–1894. doi: 10.1093/jn/nxy223

TABLE 2.

Purine metabolites in infants fed SF, HM, or MF1

Metabolite Multiplier2 SF HM MF
Adenosine 1000,000 242 ± 129b 135 ± 71 167.3 ± 78.2
ADP 1000 34 ± 27b 7 ± 5 10.6 ± 6.6
AICAR 10,000 92 ± 293 3 ± 2 10.2 ± 10.0
Allantoin 100,000 13 ± 14 9 ± 10 7.7 ± 6.3
AMP 100,000 21 ± 39b 1 ± 1 1.6 ± 1.5
ATP 100,000 12 ± 26 0.1 ± 0.1 0.0 ± 0.0
cAMP 100,000 88 ± 79b 35 ± 25 51 ± 33
GDP 1000 57 ± 52b 32 ± 22 31 ± 26
GMP 1000 60 ± 52b 10 ± 9 22 ± 26
GTP 1000 69 ± 51b 9 ± 9 34 ± 33
Guanine 1000,000 68 ± 38b 35 ± 20 45 ± 21
Guanosine 10,000 29 ± 22b 14 ± 8 20 ± 9
Hypoxanthine 1000,000 84 ± 73a 75 ± 51 91 ± 47
IMP 10,000 21 ± 25b 3 ± 3 6 ± 6
Inosine 1000,000 14 ± 9b 12 ± 7 14 ± 10
PRPP 100,000 32 ± 21b 14 ± 10 28 ± 16
Uric acid 1000,000 166 ± 179b 40 ± 35 63 ± 52
Xanthine 1000,000 83 ± 50a 77 ± 48 81 ± 67
Xanthosine 1000,000 17 ± 23b 5 ± 3 7 ± 8
XMP 100 77 ± 79a 12 ± 13 31 ± 19

1Values are mean ± SD peak intensity (n = 13 for SF, 14 for HM, and 13 for MF) normalized by the total number of peaks and per millimole of creatinine.

a P < 0.05 vs. HM group.

b P < 0.05 vs. HM and MF groups. AICAR, 5-aminoimidazole-4-carboxamide ribonucleotide; HM, human milk; IMP, inosine monophosphate; MF, milk formula; PRPP, 5-phospho-α-d-ribosyl 1-pyrophosphate; SF, soy formula; XMP, xanthosine monophosphate.

2Multiplication factor to be used to calculate the peak counts.